Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | RAD51L3 |
Upstream (Parents) |
---|
(<<) CASP9 → RAD51L3 |
(<<) CBL → RAD51L3 |
(<<) CEP170 → RAD51L3 |
(<<) DDX21 → RAD51L3 |
(<<) IVL → RAD51L3 |
(<<) MAP2K3 → RAD51L3 |
(<<) MAP3K12 → RAD51L3 |
(<<) PIK3R5 → RAD51L3 |
(<<) PRKCQ → RAD51L3 |
(<<) RAB5B → RAD51L3 |
(<<) RPS16 → RAD51L3 |
(<<) THRB → RAD51L3 |
Downstream (Children) |
---|
RAD51L3 → ACTA2 (>>) |
RAD51L3 → ADAM19 (>>) |
RAD51L3 → ATP2B4 (>>) |
RAD51L3 → BRCA1 (>>) |
RAD51L3 → CASP10 (>>) |
RAD51L3 → CASP2 (>>) |
RAD51L3 → CASP4 (>>) |
RAD51L3 → CASP6 (>>) |
RAD51L3 → CEBPD (>>) |
RAD51L3 → CHI3L1 (>>) |
RAD51L3 → CHST7 (>>) |
RAD51L3 → COX6A2 (>>) |
RAD51L3 → CREBBP (>>) |
RAD51L3 → CTNNB1 (>>) |
RAD51L3 → CYP27B1 (>>) |
RAD51L3 → DNAJA4 (>>) |
RAD51L3 → DYNC1LI2 (>>) |
RAD51L3 → E2F4 (>>) |
RAD51L3 → ETS1 (>>) |
RAD51L3 → FERMT1 (>>) |
RAD51L3 → FGF5 (>>) |
RAD51L3 → FUT1 (>>) |
RAD51L3 → GNAQ (>>) |
RAD51L3 → GNAS (>>) |
RAD51L3 → GNG11 (>>) |
RAD51L3 → GNG4 (>>) |
RAD51L3 → GRK5 (>>) |
RAD51L3 → GSK3A (>>) |
RAD51L3 → HS3ST2 (>>) |
RAD51L3 → IL1RN (>>) |
RAD51L3 → ITGA7 (>>) |
RAD51L3 → KRT1 (>>) |
RAD51L3 → KRT16 (>>) |
RAD51L3 → LIMK1 (>>) |
RAD51L3 → MAP3K6 (>>) |
RAD51L3 → MAP3K9 (>>) |
RAD51L3 → MAPK7 (>>) |
RAD51L3 → MRAS (>>) |
RAD51L3 → MYH14 (>>) |
RAD51L3 → MYL7 (>>) |
RAD51L3 → NFKB2 (>>) |
RAD51L3 → ORM1 (>>) |
RAD51L3 → PI3 (>>) |
RAD51L3 → PIK3C3 (>>) |
RAD51L3 → PPP2R5C (>>) |
RAD51L3 → PTGER1 (>>) |
RAD51L3 → ROBO3 (>>) |
RAD51L3 → RPL36 (>>) |
RAD51L3 → RXRB (>>) |
RAD51L3 → SLC26A1 (>>) |
RAD51L3 → SMOX (>>) |
RAD51L3 → SOX1 (>>) |
RAD51L3 → SRC (>>) |
RAD51L3 → SULT4A1 (>>) |
RAD51L3 → TAF9 (>>) |
RAD51L3 → TEX10 (>>) |
RAD51L3 → TGFA (>>) |
RAD51L3 → TGM2 (>>) |
RAD51L3 → THRA (>>) |
RAD51L3 → TPM2 (>>) |
RAD51L3 → TYK2 (>>) |
RAD51L3 → WNT6 (>>) |
RAD51L3 → ZBED2 (>>) |
RAD51L3 → ZFP36L1 (>>) |